RMD RSI

What is RMD?

ResMed started back in 1989 when Peter Farrell took a gamble on commercializing a prototype for treating sleep apnea. Since then, the company has grown from a niche Australian startup into a San Diego-based global leader in respiratory medicine. Their core business model focuses on creating a seamless ecosystem for patients with chronic conditions like obstructive sleep apnea and COPD. They do this by combining high-quality hardware with cloud-based software that allows doctors and patients to track health data in real time.

Their product lineup is led by the AirSense series of CPAP machines and various ergonomic mask interfaces. Beyond the physical hardware, ResMed has built a massive software-as-a-service business through key acquisitions like Brightree and MatrixCare. These platforms help out-of-hospital care providers manage their workflows more efficiently. Historically, the company hit its biggest stride around 2014 when it committed fully to cloud connectivity. This move turned them from a simple equipment manufacturer into a data-driven digital health powerhouse with millions of connected devices worldwide.

Financially, ResMed is in a solid spot. They have historically enjoyed high margins and strong cash flow, which has allowed for consistent dividend growth. While they recently navigated some supply chain constraints and the ripple effects of a major competitor's recall, they managed to capture significant market share during that period. Their balance sheet remains robust enough to support ongoing research and development as well as strategic tuck-in acquisitions.

Looking toward 2026, the strategy is focused on AI integration and market expansion. While some investors worry about weight-loss drugs reducing the sleep apnea patient pool, ResMed views this as a potential tailwind for diagnosis. They plan to use AI to better identify undiagnosed patients and integrate their digital platforms with broader wellness management programs. The goal for 2026 is to have hundreds of millions of people benefiting from their digital health ecosystem, focusing on personalized, home-based care.

What is RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and magnitude of price changes. Developed by J. Welles Wilder, RSI ranges from 0 to 100 and helps traders identify overbought or oversold conditions in an asset.

For RMD, monitoring the RSI provides valuable insights into potential trend reversals and entry/exit points. When the RSI drops below 30, ResMed Inc. is typically considered oversold, suggesting the asset may be undervalued. Conversely, an RSI above 70 indicates overbought conditions.

Understanding RMD RSI Signals

• Oversold (RSI below 30): When RMD RSI falls below 30, it suggests the asset may have been sold off excessively and could be due for a bounce. This is often viewed as a potential buying opportunity, though it's important to consider other factors and not rely solely on RSI.
• Overbought (RSI above 70): An RSI above 70 indicates RMD may be overbought, potentially signaling a pullback or consolidation phase. Traders often use this as a signal to take profits or wait for better entry points.
• Divergences: When RMD price makes new highs or lows but RSI doesn't confirm these moves, it can signal weakening momentum and a possible trend reversal.

Daily vs Weekly RSI for RMD

This page displays both daily and weekly RSI for RMD. The daily RSI responds quickly to short-term price movements, making it useful for day traders and swing traders. The weekly RSI provides a broader perspective on momentum trends, helping longer-term investors identify major oversold or overbought conditions.

By analyzing both timeframes together, you can better understand ResMed Inc.'s momentum at multiple levels and make more informed trading decisions.

Historical RSI Oversold Analysis

Above, we track historical instances when RMD RSI dropped below 30 (oversold territory). Reviewing these past oversold levels helps identify patterns and understand how ResMed Inc. has historically responded to oversold conditions. Many traders use these historical reference points to gauge potential support levels and timing for entry positions.